Nutex Health (NASDAQ:NUTX) Sets New 12-Month High – Should You Buy?

Shares of Nutex Health Inc. (NASDAQ:NUTX) reached a new 52-week high on Thursday . The company traded as high as $201.49 and last traded at $193.9440, with a volume of 31238 shares traded. The stock had previously closed at $190.71.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on NUTX. Weiss Ratings upgraded shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, May 4th. B. Riley Financial initiated coverage on shares of Nutex Health in a report on Friday, June 26th. They set a “buy” rating and a $290.00 price target for the company. Lake Street Capital assumed coverage on shares of Nutex Health in a research report on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 price objective on the stock. Wall Street Zen upgraded shares of Nutex Health from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Finally, Zacks Research raised shares of Nutex Health to a “hold” rating in a research report on Monday. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $243.33.

Nutex Health Trading Up 0.2%

The firm has a market cap of $1.31 billion, a PE ratio of 14.76 and a beta of 0.21. The company has a current ratio of 3.14, a quick ratio of 3.12 and a debt-to-equity ratio of 0.66. The business has a fifty day moving average price of $133.49 and a 200 day moving average price of $129.94.

Nutex Health (NASDAQ:NUTX) last issued its earnings results on Thursday, April 30th. The company reported $6.52 earnings per share for the quarter, topping the consensus estimate of $3.99 by $2.53. The business had revenue of $216.49 million for the quarter, compared to analyst estimates of $227.80 million. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%. Analysts forecast that Nutex Health Inc. will post 22.72 EPS for the current year.

Institutional Trading of Nutex Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Pertento Partners LLP acquired a new position in shares of Nutex Health in the 3rd quarter valued at $27,940,000. Topline Capital Management LLC raised its stake in Nutex Health by 80.0% during the 3rd quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock worth $57,505,000 after acquiring an additional 247,436 shares in the last quarter. Millennium Management LLC raised its stake in Nutex Health by 191.1% during the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock worth $9,650,000 after acquiring an additional 61,308 shares in the last quarter. Empowered Funds LLC purchased a new stake in Nutex Health in the first quarter valued at $3,084,000. Finally, SG Americas Securities LLC lifted its position in Nutex Health by 3,232.6% in the first quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock valued at $2,885,000 after acquiring an additional 29,449 shares during the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.